FMR CORP 13D/13G Filings for Fate Therapeutics, Inc. (FATE)

FMR CORP 13D and 13G filings for Fate Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-10-12
09:25 am
Sale		 2021-10-08 13G Fate Therapeutics, Inc.
FATE		 FMR CORP 2,249,450
2.363%		 -5,355,454decrease
(-70.42%)		 Filing
2021-02-08
10:21 am
Purchase		 2021-02-05 13G Fate Therapeutics, Inc.
FATE		 FMR CORP 7,604,904
8.716%		 719,321increase
(+10.45%)		 Filing